LEQSELVI
Live / Registered — Registered (as of 03 Mar 2026)
What this means for you
Registered since 03 Mar 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98567738
- Registration number
- 8162853
- Mark type
- Design + words
- Filed
- 24 May 2024
- Published for opposition
- 31 Dec 2024
- Registered
- 03 Mar 2026
- Attorney of record
- Craig Kuchii
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of autoimmune and inflammatory diseases and disorders; pharmaceutical preparations for the treatment of skin disorders; pharmaceutical preparations for the treatment of hair loss disorders; pharmaceutical preparations, namely, medicated dermatological preparations; pharmaceutical preparations for the treatment of alopecia areata; none of the aforesaid being pharmaceuticals for the treatment of cardiovascular diseases
Owner
- Sun Pharmaceutical Industries, Inc., Princeton, NJ, US
- Sun Pharmaceutical Industries, Inc., Princeton, NJ, US
- Sun Pharmaceutical Industries, Inc., Princeton, NJ, US
Prosecution history
- 03 Mar 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 03 Mar 2026 — REGISTERED-PRINCIPAL REGISTER
- 06 Feb 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 06 Feb 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 17 Jan 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 17 Jan 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 17 Jan 2026 — ASSIGNED TO LIE
- 14 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Jan 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 14 Jan 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 14 Jan 2026 — NON-FINAL ACTION E-MAILED
- 14 Jan 2026 — SU - NON-FINAL ACTION - WRITTEN
- 14 Jan 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 22 Aug 2025 — USE AMENDMENT FILED
- 14 Jan 2026 — SOU EXTENSION 1 GRANTED